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A B S T R A C T
Background: Screening for TB (tuberculosis) among socially marginalized citizens has been implemented
in many urban areas in countries with a low incidence of TB, including Denmark. This study aims to
describe the findings of the screening programs for TB and latent tuberculosis (LTBI) used in the western
part of Denmark in the period 2014–2019.
Methods: Data was collected retrospectively on test results from interferon-gamma release assays (IGRA),
spot sputum tests and chest X-rays performed as part of TB and LTBI screening among 1024 socially
marginalized citizens in urban areas of western Denmark in 2014–2019.
Results: The overall TB incidence was 2148/100.000 and number needed to screen to find one TB case was
39. The incidence of LTBI in the group screened using IGRA was 17.500/100.000. TB incidence when using
spot sputum test was 2.5, while TB incidence when using IGRA as the primary screening test was 2.7. In
total, 38.9% of TB diagnoses were obtained after the second or third round of screening.
Conclusion: We demonstrated a high incidence of TB and LTBI among socially marginalized citizens in
Denmark. Screening with spot sputum testing and IGRA generated comparable results in diagnosing TB in
this setting.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
Introduction
In Denmark, as in many countries with low TB incidence, TB is to
a large extent only seen in immigrants from countries with high TB
incidence and in high-risk groups such as people with drug or
alcohol addiction, and homeless people (ECDC, 2016; Gupta et al.,
2018; Kruse et al. 2018; Lillebaek et al., 2012; WHO, 2015). Focus
should be on these groups when TB prevention and eradication
strategies are planned (ECDC, 2016; Gupta et al., 2018; Kruse et al.,
2018; Lönnroth et al., 2015; de Vriers et al., 2014). A study from the
Copenhagen area in Denmark found a TB prevalence of 2233/
100.000 among socially marginalized people screened with a
single sputum test (Jensen et al., 2015), while a study from Aarhus,
Denmark found 0.8% with TB and 13% with LTBI in screening at a
homeless shelter in 2014 (Staerke et al., 2016). Similar TB incidence
has been reported from screening among socially marginalized
persons in cities across low-incidence countries such as France,
Spain, United Kingdom, United States and Germany (Badiaga et al.,
2009; Bernard et al., 2012; Goetsch et al., 2012; Jimenez-Fuentes
et al., 2014; Miller et al., 2006; Story et al., 2012; de Vries et al.,
2007). These studies provide evidence of an ongoing problem with
TB in the vulnerable, socially marginalized citizens. Due to these
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centers and street clinics has been set up in several large cities of

































N.B. Staerke, T. Smidt-Hansen, L. Oldenborg et al. International Journal of Infectious Diseases 102 (2021) 352–356The incidence of TB in Denmark was 5.0/100.000 in 2018 (SSI,
019) placing the country in the low-incidence category. While a
uarter of the global population is estimated to have LTBI (Cohen
t al., 2019; Houben and Dodd, 2016) the prevalence of LTBI is
stimated to be as low as 1.2–4.2% in Denmark (Houben and Dodd,
016); however, data on the prevalence of LTBI in high-risk groups is
imited. The aim of this study is to describe the findings of systematic
onsecutive screening for TB and LTBI among socially marginalized
ersons in urban areas of Denmark, and to assess the yield of using
pot sputum testing versus IGRA and chest X-ray. This study presents
he results from TB screenings among homeless and other socially
arginalized high-risk citizens in the cities of Aarhus, Aalborg and
sbjerg through the years 2014–2019.
ethods
aterials and study population
Data from TB screenings performed in Esbjerg (2014–2019),
alborg (2016–2019) and Aarhus (2017–2019) was collected
etrospectively for this study. These three cities are the largest
ities in the Danish region of Jutland. Data was drawn from local
atabases and electronic patient records and anonymized.
Screening was carried out approximately once per year, with a
eam of nurses and doctors visiting the screening sites and offering
esting to everyone present.Testingwasofferedathomeless shelters,
emporary housing facilities and drop-in centers; the target group
eing users of these facilities. The screening rounds were planned in
ollaboration with the municipalities and announced to users of the
acilities in advance in order to increase attendance. Data was
ollected from local databases and patient records, including: results
rom any screening tests applied (IGRA, spot sputum testing and
hest X-ray); data on previously diagnosed TB or LTBI; and data on
ge and gender of screening participants.
esting strategies
Two different testing strategies were used in the screening
rograms during the study period. At some screening rounds an
IGRA test was used as the primary screening test for TB naive
subjects, targeting both LTBI and TB, and an X-ray used as the
primary screening test for persons who had previously had LTBI or
TB. In other screening rounds a single spot sputum test was used as
the primary test exclusively targeting TB (Figure 1). These two
methods where applied at different time points in the three cities
depending on factors such as practical conditions e.g., allowing for
blood sampling, resources and the opinion of the local doctors
responsible for the screening program.
IGRA tests used were either QuantiFERON1-TB Gold Plus
(QIAGEN GmbH, QIAGEN Strasse 1, 40724 Hilden, Germany) or T-
SPOT1.TB (Oxford Immunotec Global PLC, 143 Park Drive, Milton
Park, Abingdon, Oxfordshire, United Kingdom). Both were used
according to the instructions and analyzed at licensed laboratories at
Statens Serum Institut, Artillerivej 5, 2300 København S., Denmark,
or the Research Laboratoryat the Department of Pulmonary Diseases
at Aarhus University Hospital, Nørrebrogade 23B, 8000 Aarhus C.
All sputum samples were analyzed at the Department for
Tuberculosis and Mycobacteria at Statens Serum Institut, Artiller-
ivej 5, 2300 København S, Denmark. All samples underwent
microscopy for acid-fast bacilli, and culture for mycobacteria for 56
days. PCR-testing for Mycobacterium tuberculosis complex was
performed only on request from the physician.
Statistics
Data were analyzed using Microsoft Excel and Stata, version 14
(StataCorp, College Station, TX). Data are presented as proportions
and percentages. Prevalence of TB and LTBI was calculated using the
results of eachperson’s first test result,dividedby the total numberof
subjects. The effect of screening for TB and LTBI are expressed as
percentage of positive test results using each test strategy, and by
number needed to screen (NNS). Proportions were compared using
student’s chi-square test, applying a significance level of 0.05.
Results
In total, 1024 persons were tested in one or more screening
rounds, yielding a total of 1399 screening tests. Uptake wasigure 1. Flow chart of screening procedures. (a) Person 1 is TB naive, person 2 has previous TB or LTBI. TB examination includes microscopy, PCR and culture of relevant
aterial (sputum, bronchoalveolar lavage fluid, gastric lavage fluid etc.) and physical exam. (b) Spot sputum examination includes microscopy, PCR and culture.
353
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homeless in the three cities combined in 2019 (Benjaminsen, 2019)
and in a sample of the persons screened in Aarhus, Aalborg and
Esbjerg 28% were homeless (data not yet published). Assuming
that the proportion of homelessness is the same in the untested
population the eligible population would be 4186 persons.
Overall, 8.1% (113/1399) of tests resulted in a diagnosis of either
TB or LTBI. 67.7% of the screened population were men and there
was a mean age of 50 (range 15–87). Spot sputum testing was
performed as the primary test in 758 persons (54.2%), while 469
(33.5%) and 172 (12.2%) were tested with IGRA or X-ray,
respectively (Table 1).
Active tuberculosis
A total of 36 cases of TB were found through screening. Overall,
the yield of TB screening was 2.6% (36/1399) and the NNS to find
one case of TB was 39. The prevalence of TB, calculated from first
screening instance, was 22/1024 (2.15%) or 2.148/100.000. In total,
241 persons completed two or more screening rounds and 14/36
(38.9%) of the TB diagnoses were made at second or third screening
(Table 2). Only 51 persons completed four or more screening
rounds and no additional TB cases were found among these. In
total, 19/36 cases of TB (52.8%) were found using spot sputum
testing, while 8/36 cases (22.2%) were found with the IGRA test and
9/36 with X-ray (25%). Combining IGRA for TB naïve subjects with
X-ray for those with previous TB or LTBI revealed a TB rate of 2.7%
and NNS of 38, while spot sputum testing had a positive rate of 2.5%
and NNS of 40 (p = 0.86).
All TB cases were confirmed with sputum samples evaluated
using culture and microscopy. PCR for mycobacterium tuberculosis
was carried out in 27/36 cases (75%) and in 10 cases (37%) the PCR
test was positive. In 20 cases (55.6%) the sputum samples were
culture positive for TB but smear negative. When using spot
sputum tests as the primary screening test, 10/19 samples that
were culture positive for TB (52.6%) were smear negative. Of 17
culture-positive TB cases the 17 cultures that were positive for TB
that were found using primary IGRA screening, 10 (58.8%) were
smear negative (p = 0.84) (Table 1).
Latent tuberculosis
In 469 instances, an IGRA test was used as the primary-test was
used as the primary test. Hereof, 98 were positive, whereof 77
subjects were diagnosed with latent tuberculosis, 8 with active
tuberculosis, 12 were inconclusive due to loss to follow-up and 1
had previous active TB Figure 2). Calculated at the first instance of
IGRA-testing, we found an LTBI incidence of 70/400 (17.5%) or
17.500/100.000 was identified. Of the patients diagnosed with LTBI
34 (44%) received chemoprophylaxis while 43 (56%) either
declined treatment, were lost to follow-up, or were deemed not
eligible for treatment by the treating physician (Table 3).
Discussion
In this study, high rates of TB and LTBI were identified among
socially marginalized persons tested in screening programs.
Furthermore, detection rates of active TB stayed high for subjects
tested at up to three consecutive screening rounds. Additionally,
similar detection rates for TB using two different screening
strategies – spot sputum testing and IGRA supplemented with
X-ray – were identified.
The high incidence of active and latent TB identified underlines
the importance of active case finding focused on the vulnerable
group of socially marginalized citizens. A systematic review of
active case finding strategies among the homeless describes a yield
from 0 to 3.1% for TB (Hamilton et al., 2018) placing the screening
programs described in this study in the high end of the spectrum
Table 1





Age, years, mean (range) 50 (15–87) 48 (29–60)
Sex
Female 452 (32.3%) 12 (33.3%)
Male 947 (67.7%) 24 (66.7%)
City
Aarhus 565 (40.4%) 6 (1.1%)
Esbjerg 409 (29.2%) 19 (4.6%)
Aalborg 425 (30.4%) 11 (2.6%)
Total 1399 (100%) 36 (2.6%)
Primary test
Sputum 758 (54.2%) 19 (2.5%)
IGRA or X-ray 641 (45.8%) 17 (2.7%)
IGRA 469 (33.5%) 8 (2.0%)
X-raya 172 (12.3%) 9 (5.2%)
Table 2
Results from consecutive TB screening tests. Screened population and number of TB
cases identified by number of screening rounds completed.
Number of screening
rounds completed
Screened population TB cases (%)
1 1024 22 (2.15%)
2 241 11 (4.6%)
3 83 3 (3.6%)
4–7 51 0
Figure 2. Results from IGRA-testing.
Table 3
Demography of the population screened for LTBI.
Screened population
(n = 469)
LTBI (n = 77)
Age, years, mean (range) 51 (15–81) 53 (20–71)
Sex
Female 170 (36.2%) 18 (23.4%)
Sputum results
Positive microscopy 14 (38.9%)
Positive PCR 10 (37.0%b)
Positive microscopy or PCR 16 (44.4%)
Positive culture 36 (100%)
a Persons with previous LTBI or TB.
b PCR was performed in 27 cases.
Male 299 (63.8%) 59 (76.6%)
City
Aarhus 124 (26.4%) 17 (13.7%)
Esbjerg 237 (50.5%) 43 (18.1%)
Aalborg 108 (23.1%) 17 (15.7%)
Total 469 (100%) 77 (16.4%)

































































N.B. Staerke, T. Smidt-Hansen, L. Oldenborg et al. International Journal of Infectious Diseases 102 (2021) 352–356ith an overall yield of 2.6% (36/1399). Notably the TB incidence
dentified is similar to that seen in Copenhagen (Jensen et al., 2015)
uggesting that TB transmission among the socially marginalized is
 country-wide issue in Denmark.
The high TB prevalence shows that the screening programs
each a relevant population, however, it may also suggest that
esting is too limited resulting in cases going undetected. From our
stimate as many as 3/4 of those eligible for screening did not
ttend; the rate of TB in the untested group is unknown. A Swiss
tudy reporting results from TB screening among the homeless
ound that attending screening was associated with male gender,
ge below 25 years and homelessness for less than 12 months
Janssens et al., 2017). A study from Atlanta, USA, found that
eturning for reading ofa reading of a tuberculin skin test was more
ikely for those who knew someone with TB, did not misuse drugs
r alcohol, had completed high-school and had attended screening
efore (Bock et al., 1999). These findings are ambiguous as to
hether the untested population can be expected to be at high risk
or TB, as substance misuse, homelessness and having close
ontacts with TB are all known risk factors for developing TB.
owever, it is evident that a large proportion of the eligible
opulation opt out of screening and efforts should be made to
ncrease attendance to the screening programs, possibly through
ffering incentives, which has been shown to be effective
Hamilton et al., 2018).
The study was not able to determine whether one of the two
est strategies is superior to the other in detecting TB as both the
ield and the rate of smear test negative cases in the two strategies
ere almost equal. The use of the spot sputum test for TB screening
as evaluated in a similar setting by Jensen et al. (2015) where a
omparable yield was described. A major issue with using the
urrently available IGRAs for TB screening is the suboptimal
ensitivity described by Whitworth et al. (2019). According to their
ndings combinations with newly discovered M. tuberculosis
ntigens may increase sensitivity and when new generations of
GRAs are developed these should be evaluated for screening use.
he spot sputum test is simple to retrieve but is unable to diagnose
TBI and thereby be useful in the prevention of TB transmission
hrough chemoprophylaxis or close follow-up of patients with
TBI. The choice of test strategy should be based on a careful
valuation of the subset of the population that the particular
creening round is targeting. Some parts of the population may be
asier to access for prophylactic treatment and close follow-up, in
hese cases using an IGRA test either as the primary screening test
r in combination with another test could be an advantage.
All TB cases identified in this study were culture-positive This
eflects that a sputum culture test was used either as the only test
erformed, or as the confirmation test following a positive IGRA or
n X-ray suggestive of TB. It is well known that a significant
roportion of TB cases found during passive case finding are
ulture-negative for TB, hence the diagnosis is reached by clinical
nd radiological investigations without microbiological evidence.
ases may therefore have been missed that would have been
udged culture-negative for TB in a more comprehensive investi-
ation. However, in a screening for TB, the objective is to detect TB
ases among those not presenting for clinical evaluation due to
haracteristic symptoms. A full clinical and radiological evaluation
s neither feasible, nor ethical, in this context. One could view
ulture-positivity as the threshold accepted as the lower level of
etection under these circumstances. According to Frascella et al.
second or third screening round may have been detected initially
in a conventional diagnostic setup, applying, for example, CT scans
and bronchoscopy sampling.
PCR for M. tuberculosis complex was performed on 27/36 (75%)
of the culture confirmed samples and in 10 of 27 cases (37%) the
test was positive suggesting a lower sensitivity of PCR as opposed
to culture. Nevertheless, PCR has the advantage of a faster result,
and hence, when positive, will lead to earlier treatment which
favors its routine use in this setting.
Different rates of TB where found in the three cities which
probably reflects a difference in demography of the population of
socially marginalized people between the cities with regards to
risk factors such as ethnic origin in a country with high TB
prevalence or substance abuse, but may also reflect differences in
how widely screening was offered.
The material in this study was collected retrospectively which
entails a limitation to the comparison of the test strategies as the
subjects were not randomized and there were no considerations
regarding clustering of cases. As the information obtained for this
study was anonymized the amount of information about the
individual subjects is very limited including individual risk factors
such as homelessness, substance abuse and country of origin; this
is also a limitation to this study.
In conclusion, this study demonstrated a high rate of TB and
LTBI among socially marginalized citizens in Denmark, with
comparable yield using two different screening strategies. A large
number of TB cases were found to be sputum smear-negative,
possibly reflecting an early disease stage and a low risk of disease
transmission. These findings provide new knowledge about
screening and management of TB and LTBI among socially
marginalized citizens and may build on the experience necessary
to reduce the number of new TB cases and the spread of the disease
in this vulnerable high-risk population and ultimately reach the
goal of TB elimination.
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